Stock CMPS COMPASS PATHWAYS PLC
Add to a list
To use this feature you must be a member
Log inSign up

News COMPASS Pathways plc

Equities

CMPS

US20451W1018

Market Closed - Nasdaq
Other stock markets
 01:30:00 03/05/2024 am IST 		5-day change 1st Jan Change
8.25 USD -2.71% Intraday chart for COMPASS Pathways plc +1.85% -5.71%
29/04 Compass Pathways and Journey Clinical Establish Research Collaboration Agreement to Inform the Training of Healthcare Providers and Delivery Model for Comp360 Psilocybin Treatment, If Approved for Treatment-Resistant Depression CI
18/04 Compass Pathways Insider Sold Shares Worth $597,964, According to a Recent SEC Filing MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment
GL
Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression
GL
Compass Pathways and Journey Clinical Establish Research Collaboration Agreement to Inform the Training of Healthcare Providers and Delivery Model for Comp360 Psilocybin Treatment, If Approved for Treatment-Resistant Depression
CI
Compass Pathways Insider Sold Shares Worth $597,964, According to a Recent SEC Filing
MT
Compass Pathways Insider Sold Shares Worth $597,964, According to a Recent SEC Filing
MT
Clarify Pharma to change name to File Forge Technology
AN
Compass Pathways Insider Sold Shares Worth $461,332, According to a Recent SEC Filing
MT
Compass Pathways Insider Sold Shares Worth $461,332, According to a Recent SEC Filing
MT
Compass Pathways Insider Sold Shares Worth $445,552, According to a Recent SEC Filing
MT
Compass Pathways Insider Sold Shares Worth $445,552, According to a Recent SEC Filing
MT
Morgan Stanley Initiates COMPASS Pathways at Overweight With $30 Price Target
MT
ADRs End Lower; NuCana Slides 15%
DJ
Compass Pathways Co-Founders Step Down From Board; David Norton Named Interim Chair; Shares Fall
MT
COMPASS Pathways plc Announces Board Changes
CI
Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors
GL
Compass Pathways Insider Sold Shares Worth $704,821, According to a Recent SEC Filing
MT
Compass Pathways Insider Sold Shares Worth $704,821, According to a Recent SEC Filing
MT
COMPASS Pathways : Presentation – March 2024
PU
Transcript : COMPASS Pathways plc, Q4 2023 Earnings Call, Feb 29, 2024
Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business Highlights 
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CMPS Stock
  4. News COMPASS Pathways plc